Latest Developments in Global Heor Services Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Heor Services Market

  • Healthcare
  • Apr 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In January 2025, IQVIA, a global leader in healthcare data and analytics, announced the launch of its new real-world evidence (RWE) platform, designed to offer advanced analytics and insights on treatment effectiveness, safety, and cost-efficiency. The platform integrates large-scale healthcare datasets and utilizes AI-driven algorithms to enhance decision-making for pharmaceutical companies, payers, and healthcare providers. This solution aims to optimize value-based healthcare strategies and improve patient outcomes by providing actionable insights based on real-world clinical data
  • In October 2024, Optum, a leading healthcare services company, introduced a new suite of HEOR solutions focused on payer strategies and market access. These solutions leverage real-world data, health economics models, and predictive analytics to support the development of evidence-based reimbursement strategies. The offerings aim to improve the efficiency of health systems while ensuring that patients have access to the most effective and cost-efficient treatments
  • In September 2024, the National Institute for Health and Care Excellence (NICE) in the UK released new guidelines on the incorporation of health economics evaluations in public health decision-making. These guidelines are designed to improve the use of HEOR data in healthcare policy, emphasizing the need for robust economic evaluations in the approval process for new therapies. The new guidelines aim to enhance the adoption of cost-effective treatments across the UK healthcare system
  • In September 2024, Covance, a global contract research organization (CRO), launched a new service to integrate clinical and economic data in its HEOR solutions. This service combines health outcomes research with economic modelling to help pharmaceutical companies navigate the complex landscape of market access and reimbursement. It aims to support manufacturers in demonstrating the value of their products to healthcare systems worldwide, enhancing product adoption and improving patient care